Johnson & Johnson Consolidated Statements of Earnings (Dollars in Millions) Fiscal 2022 Fiscal 2021 Fiscal 2020 ended January 1, 2023 Dollars % ended January 2, 2022 Dollars % ended January 3, 2021 Dollars % Sales to Customers 0.00% $ Cost of Products Sold 0.00% Gross Profit 0 0.00% 93,775 100.00% 29,855 31.84% 63,920 68.16% $ 82,584 100.00% 28,427 34.42% 54,157 65.58% Selling, Marketing and Admin Exp 0.00% 24,659 26.30% 22,084 26.74% Research and Development Exp 0.00% 14,714 15.69% 12,159 14.72% In-process R&D 0.00% 900 0.96% 181 0.22% Interest Income 0.00% (53) (0.06%) (111) (0.13%) Interest Expense, net 0.00% 183 0.20% 201 0.24% Other (Income) Expense, net 0.00% 489 0.52% 2,899 3.51% Restructuring 0.00% 252 0.27% 247 0.30% Total Expenses 0 0.00% 41,144 43.88% 37,660 45.60% Earnings Before Provision for Taxes on Income Provision for Taxes on Income Net Earnings Net Earnings Per Share Basic $ % columns may not add-up due to rounding 0 0.00% 22,776 24.29% 16,497 19.98% 0.00% 1,898 2.02% 1,783 2.16% 0.00% $ 20,878 22.26% $ 14,714 17.82% ** $7.93 ** $5.59 **